Table 2.
Capsule endoscopy findings in patients with overt and occult obscure gastrointestinal bleeding n (%)
| Parameters |
Type of OGIB |
P value | ||
| Total (n = 103) | Overt (n = 80) | Occult (n = 23) | ||
| Reaching caecum, n | 77 (74) | 60 (75) | 17 (74) | 0.916 |
| Capsule endoscopy findings, n | ||||
| Positive (P2) | 37 (36) | 28 (35) | 9 (39) | |
| Equivocal (P1) | 15 (15) | 11 (14) | 4 (17) | 0.792 |
| Negative (P0) | 51 (49) | 41 (51) | 10 (43) | |
| Etiologies, n1 | ||||
| Ulcers | 23 (44) | 15 (38) | 8 (61) | |
| Angiodysplasia | 14 (27) | 12 (31) | 2 (15) | |
| Tumors | 7 (13) | 6 (15) | 1 (8) | 0.462 |
| Miscellaneous | 4 (8) | 3 (8) | 1 (8) | |
| Active bleeding | 4 (8) | 3 (8) | 1 (8) | |
| Location of lesions, n2 | ||||
| Duodenum | 6 (13) | 4 (11) | 2 (17) | |
| Jejunum | 15 (31) | 11 (31) | 4 (33) | |
| Jejuno-ileal | 12 (25) | 9 (25) | 3 (25) | 0.969 |
| Ileum | 14 (29) | 11 (30) | 3 (25) | |
| Diffuse | 1 (2) | 1 (3 ) | 0 | |
1
Among 52 patients with P2 or P1 lesions; 39 were overt and 13 were occult obscure gastrointestinal bleeding (OGIB);
2
Data was available in 48 patients; 36 with overt and 12 with occult OGIB.